Our research

reNEW aims to create a new generation of effective, safe and socially sustainable stem cell-based therapies built on an international collaboration of excellence in biomedical research. Explore how reNEW will use stem cells as a tool and technology to change how we diagnose, treat and even prevent human disease.

reNEW Melbourne stem cell research will change the future of medicine

reNEW Melbourne researchers are pioneers at generating stem cells from any patient’s blood or skin cells, known as induced pluripotent stem cells (iPSCs). We then differentiate, or change, these iPSC into the cell type we wish to study. We can use these models of the patient’s disease to develop different strategies that may be able to repair or improve the body's function.

reNEW Melbourne researchers are leading the following projects, in collaboration with members across reNEW, that aim to push stem cell research towards therapies for patients.

Fundamental research underpins translation

Our reNEW Melbourne EXPLORE research advances our knowledge of human pluripotent stem cells and their use in disease modelling, drug discovery and regenerative medicine. It builds a foundation for new targeted research activities, moving us towards the translation of potential cellular therapies for patients. Read about our EXPLORE research.

Targeted collaborations towards therapies

reNEW aims to translate research into new stem cell-derived products to improve both the health and lives of people throughout the world.

reNEW Melbourne researchers are leading the following projects, in collaboration with members across reNEW, that aim to push stem cell research towards therapies for patients. Read about our targeted research projects.

Towards socially robust stem cell therapy

Stem cell medicine offers hope to many living with serious conditions not adequately addressed by currently available therapies. Discoveries in reNEW and other major initiatives across the globe continue to make progress towards innovative solutions involving cell and gene therapies, tissue engineering, regeneration, and identification of novel and safer drugs using stem cell research. At the same time there are also significant ethical, legal, sociocultural and health economic implications that need to be considered in concert with such developments.

To meet these challenges, PREPARE aims to bridge the gap between biomedical research, the clinical, regulatory bodies, commercial sectors, patients and publics. Read about our PREPARE research.